This is just a thought and pure speculation on my part. I
This is just a thought and pure speculation on my part. I personally think the actions of the $5 million dollar investor (the investor) has forced the company to take action sooner rather than later. Unless I'm mistaken, the record date for the shareholder meeting is February 6. As of that date, if it comes to a vote, OWC still has enough shares under their control to determine what course of action they choose to take. What would happen if the investor decided to convert more of their preferred shares?
The conversion of 35 preferred shares meant that the company had to issue 7.5 million shares to the investor during a time when the shares were traded between a range of $.10 to $.14. Not sure of exactly the math that was used because the average share price once the converted shares were converted came to approx. $.047!! Based on what I read in the loan agreement I fail to see how such a huge discount was applied. Maybe the company goofed with their math and issued more shares to the investor than they needed to. I know that there is a dispute resolution mechanism within the agreement that either side could exercise, but obviously it wasn't utilized. To try and find out from management why the average per share price after conversion was so low, is a moot point now but probably worth asking when Howie is there.
If the investor were to exercise their right to convert more preferred shares now, using the same relative calculations as above, the company might have to issue them 25 million common shares or more for the same number of 35 preferred shares. They might eventually gain control, but they would be driving the share price further and further down.
Maybe the existing management and their new CFO are smarter than we've given them credit for. It could be that they are just sending a message to the investor that is plain and simple. You fuck with us, we will fuck with you!!
2
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Top 5 Most Recently Viewed Articles
Cineverse Expands Its Popular 'Dog Whisperer' Channel Cineverse (NASDAQ: CNVS), an innovative entertainment studio, is set to enhance viewer experience by launching its hit channel, "Dog Whisperer," on Samsung TV Plus. This new collaboration allows fans of the beloved animal series to access it through a widely appreciated free, ad-supported television (FAST) service,...
Continue Reading
A Strategic Move in Stroke Recovery Sometimes, the grunt work behind real medical breakthroughs has nothing to do with shiny robots or magic pills. It's all about the grind—like trainers pushing weights with grit. Enter MindMaze Therapeutics. This Swiss company isn't just tossing tech around like confetti at a parade. Nah, they're knee-deep in a University of Pittsburgh...
Continue Reading
Standex International Corporation Under Investigation Bragar Eagel & Squire, P.C., a prominent law firm specializing in shareholder rights, has initiated an investigation into Standex International Corporation (SXI). This inquiry aims to uncover whether the company's board of directors may have neglected their fiduciary duties toward the shareholders. Understanding these...
Continue Reading
Exciting Leadership Change at the Auction of Washington Wines The Auction of Washington Wines is proud to announce the appointment of Katie Maltais as its new Executive Director. This leadership change is particularly exciting as Maltais brings a wealth of experience and a commitment to community support. Known for her innovative strategies and dedication to...
Continue Reading
Introduction to LandGate®'s Data Center Report LandGate® has unveiled its extensive report titled "Q2 2025 U.S. Data Center Development Summary," highlighting significant growth within the data center sector. This release comes in response to the growing demand for advanced AI-powered computing technologies. The findings within the report portray a landscape that is not...
Continue Reading
